Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›Accenture Stock (ACN)
Track Accenture stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
ACN
Accenture
technology
At close
$209.06
▲ +0.70 (+0.34%)
Oct 9, 4:00 PM ET
After-hours
$208.93
▼ -0.13 (-0.06%)
Oct 9, 7:59 PM ET
Market Cap
$127.93B
P/E Ratio
15.3x
1Y Return
-14.30%
EPS (TTM)
$13.57
Read the latest TheStreet Pro articles mentioning Accenture, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
45 articlesDaily Diary Mentions
3 mentionsUpside, Downside Movers in the Morning Key Observation Software/consulting/security are death ( ( CRM ) , ( ADBE ) , ( ACN ) , ( CRWD ) )
Read in context ›Defense Contracting Reuters is reporting that the U.S. Navy and U.S. Air Force are possibly considering cancelling two nearly completed software contracts and reopening the bidding to other platforms that had not been previously available.…
Read in context ›




